Recently, some researchers demonstrated that pharmacologic inhibition of PTP1B in microglia effectively reduced detrimental microglial activation, attenuated inflammatory response, and protected neuronal death after cerebral ischemia/reperfusion injury [39]. This evidence concerns the gene PTPN1 and brain ischemia.